EC0565

an mTOR inhibitor; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Cross, Vicky A: 1 article (07/2015)
2.	Gehrke, Mark A: 1 article (07/2015)
3.	Hahn, Spencer J: 1 article (07/2015)
4.	Klein, Patrick J: 1 article (07/2015)
5.	Kleindl, Paul J: 1 article (07/2015)
6.	Leamon, Christopher P: 1 article (07/2015)
7.	Low, Philip S: 1 article (07/2015)
8.	Lu, Yingjuan: 1 article (07/2015)
9.	Parker, Nikki: 1 article (07/2015)
10.	Santhapuram, Hari Krishna R: 1 article (07/2015)

1.	Rheumatoid Arthritis 07/08/2015 - "The in vivo activity of EC0565 was assessed in rats with adjuvant arthritis, a "macrophage-rich" model with close resemblance to rheumatoid arthritis. "
2.	Experimental Arthritis 07/08/2015 - "The in vivo activity of EC0565 was assessed in rats with adjuvant arthritis, a "macrophage-rich" model with close resemblance to rheumatoid arthritis. "